Zobrazeno 1 - 10
of 975
pro vyhledávání: '"Marits, P"'
Autor:
Marits, Márton
We define the cover number of a graph $G$ by a graph class $\mathcal P$ as the minimum number of graphs of class $\mathcal P$ required to cover the edge set of $G$. Taking inspiration from a paper by Harary, Hsu and Miller, we find an exact formula f
Externí odkaz:
http://arxiv.org/abs/2412.08980
We study how many comparability subgraphs are needed to partition the edge set of a perfect graph. We show that many classes of perfect graphs can be partitioned into (at most) two comparability subgraphs and this holds for almost all perfect graphs.
Externí odkaz:
http://arxiv.org/abs/2408.13523
Autor:
Milhatunnisa Marits
Publikováno v:
At-Ta'dib, Vol 17, Iss 2, Pp 304-314 (2022)
Education is the key to human life and a major factor in the development of a nation. Education is how to humanize the human race. Education lasts a lifetime and can be done anywhere. There are three primary components of education: input, process an
Externí odkaz:
https://doaj.org/article/51e21e8d1fe14c818dce8cb052244b54
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
This report illustrates a case that would have been missed in the most common screening algorithms used worldwide in newborn screening (NBS) for severe combined immunodeficiency (SCID). Our patient presented with a clinical picture that suggested a s
Externí odkaz:
https://doaj.org/article/1c268ad9a06d468c851c7b2051401294
Autor:
Ying Hua, Milan Chromek, Anne Frykman, Cecilia Jernberg, Valya Georgieva, Sverker Hansson, Ji Zhang, Ann Katrine Marits, Chengsong Wan, Andreas Matussek, Xiangning Bai
Publikováno v:
Virulence, Vol 12, Iss 1, Pp 1296-1305 (2021)
Shiga toxin-producing Escherichia coli, a foodborne bacterial pathogen, has been linked to a broad spectrum of clinical outcomes ranging from asymptomatic carriage to fatal hemolytic uremic syndrome (HUS). Here, we collected clinical data and STEC st
Externí odkaz:
https://doaj.org/article/a71e42bb48a54d3a99e7186b78938af9
Autor:
Henrik Stranneheim, Kristina Lagerstedt-Robinson, Måns Magnusson, Malin Kvarnung, Daniel Nilsson, Nicole Lesko, Martin Engvall, Britt-Marie Anderlid, Henrik Arnell, Carolina Backman Johansson, Michela Barbaro, Erik Björck, Helene Bruhn, Jesper Eisfeldt, Christoph Freyer, Giedre Grigelioniene, Peter Gustavsson, Anna Hammarsjö, Maritta Hellström-Pigg, Erik Iwarsson, Anders Jemt, Mikael Laaksonen, Sara Lind Enoksson, Helena Malmgren, Karin Naess, Magnus Nordenskjöld, Mikael Oscarson, Maria Pettersson, Chiara Rasi, Adam Rosenbaum, Ellika Sahlin, Eliane Sardh, Tommy Stödberg, Bianca Tesi, Emma Tham, Håkan Thonberg, Virpi Töhönen, Ulrika von Döbeln, Daphne Vassiliou, Sofie Vonlanthen, Ann-Charlotte Wikström, Josephine Wincent, Ola Winqvist, Anna Wredenberg, Sofia Ygberg, Rolf H. Zetterström, Per Marits, Maria Johansson Soller, Ann Nordgren, Valtteri Wirta, Anna Lindstrand, Anna Wedell
Publikováno v:
Genome Medicine, Vol 13, Iss 1, Pp 1-15 (2021)
Abstract Background We report the findings from 4437 individuals (3219 patients and 1218 relatives) who have been analyzed by whole genome sequencing (WGS) at the Genomic Medicine Center Karolinska-Rare Diseases (GMCK-RD) since mid-2015. GMCK-RD repr
Externí odkaz:
https://doaj.org/article/24239a4e507a406db912b81371637d5d
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Nastya Kharlamova, Christina Hermanrud, Nicky Dunn, Malin Ryner, Karen Hambardzumyan, Nancy Vivar Pomiano, Per Marits, Inger Gjertsson, Saedis Saevarsdottir, Rille Pullerits, Anna Fogdell-Hahn
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
A subgroup of patients treated with infliximab lose response to the treatment and one reason for this is the development of anti-drug antibodies (ADA). If used optimally, measuring drug and ADA level could lead to a more personalized and efficient tr
Externí odkaz:
https://doaj.org/article/79dbf46073304c1b828a8088bc48196f